Your browser doesn't support javascript.
loading
Effectiveness of 10 and 13-valent pneumococcal conjugate vaccines against invasive pneumococcal disease in European children: SpIDnet observational multicentre study.
Savulescu, Camelia; Krizova, Pavla; Valentiner-Branth, Palle; Ladhani, Shamez; Rinta-Kokko, Hanna; Levy, Corinne; Mereckiene, Jolita; Knol, Mirjam; Winje, Brita A; Ciruela, Pilar; de Miguel, Sara; Guevara, Marcela; MacDonald, Laura; Kozakova, Jana; Slotved, Hans-Christian; Fry, Norman K; Pekka Nuorti, J; Danis, Kostas; Corcoran, Mary; van der Ende, Arie; Vestrheim, Didrik F; Munoz-Almagro, Carmen; Sanz, Juan-Carlos; Castilla, Jesus; Smith, Andrew; Colzani, Edoardo; Pastore Celentano, Lucia; Hanquet, Germaine.
Affiliation
  • Savulescu C; Epiconcept, Paris, France.
  • Krizova P; National Institute of Public Health, Prague, Czech Republic.
  • Valentiner-Branth P; Statens Serum Institut, Copenhagen, Denmark.
  • Ladhani S; Public Health England, London, United Kingdom.
  • Rinta-Kokko H; National Institute for Health and Welfare, Helsinki, Finland.
  • Levy C; ACTIV, Créteil, France.
  • Mereckiene J; Health Protection Surveillance Centre Dublin, Ireland.
  • Knol M; National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
  • Winje BA; Norwegian Institute of Public Health, Oslo, Norway.
  • Ciruela P; Health Agency of Catalunya, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain.
  • de Miguel S; General Directorate of Public Health Madrid, Spain.
  • Guevara M; Public Health Institute of Navarra - IdiSNA, Pamplona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain.
  • MacDonald L; Public Health Scotland, Glasgow, Scotland, UK.
  • Kozakova J; National Institute of Public Health, Prague, Czech Republic.
  • Slotved HC; Statens Serum Institut, Copenhagen, Denmark.
  • Fry NK; Public Health England, London, United Kingdom.
  • Pekka Nuorti J; National Institute for Health and Welfare, Helsinki, Finland; Tampere University, Tampere, Finland.
  • Danis K; Santé publique France, the National Public Health Institute, Saint-Maurice, France.
  • Corcoran M; Temple Street Children's University Hospital, Irish Pneumococcal Reference Laboratory, Dublin, Ireland.
  • van der Ende A; Academic Medical Centre, National Reference Laboratory for Bacterial Meningitis, Amsterdam, the Netherlands.
  • Vestrheim DF; Norwegian Institute of Public Health, Oslo, Norway.
  • Munoz-Almagro C; Hospital Sant Joan de Déu, and International University of Catalunya, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain.
  • Sanz JC; General Directorate of Public Health Madrid, Spain.
  • Castilla J; Public Health Institute of Navarra - IdiSNA, Pamplona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain.
  • Smith A; Bacterial Respiratory Infection Service, Scottish Microbiology Reference Laboratory, Glasgow Royal Infirmary & MVLS, University of Glasgow, Glasgow, Scotland, UK.
  • Colzani E; European Centre for Disease Prevention and Control, Stockholm, Sweden.
  • Pastore Celentano L; European Centre for Disease Prevention and Control, Stockholm, Sweden.
  • Hanquet G; Epiconcept, Paris, France; Antwerp university, Antwerp, Belgium. Electronic address: ghanquet@skynet.be.
Vaccine ; 40(29): 3963-3974, 2022 06 23.
Article in En | MEDLINE | ID: mdl-35637067

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumococcal Infections / Streptococcus pneumoniae Type of study: Clinical_trials / Observational_studies Limits: Child / Humans / Infant Language: En Journal: Vaccine Year: 2022 Document type: Article Affiliation country: Francia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumococcal Infections / Streptococcus pneumoniae Type of study: Clinical_trials / Observational_studies Limits: Child / Humans / Infant Language: En Journal: Vaccine Year: 2022 Document type: Article Affiliation country: Francia